Xiao-Bo Tang1, Jian Wang1, Pei-Long Dong1, Rong Zhou2. 1. Department of Orthopedics, Jianhu People's Hospital of Jiangsu Province, Jianhu, P.R. China. 2. Science and Education Section, Jianhu People's Hospital of Jiangsu Province, Jianhu, P.R. China.
Abstract
BACKGROUND: This meta-analysis (MA) aims at comparing the clinical outcomes of resurfacing and nonresurfacing the patella in patients undergoing total knee arthroplasty in the treatment of knee osteoarthritis. METHODS: Randomized controlled trials were included by retrieving data from electronic English databases. Both fixed and random-effects models were employed, and standardized mean difference and 95% confidence intervals were calculated. Stata13.1 software was used for statistical analysis for all the studies included to compare the differences in improving Knee Society Clinical Score and Knee Society Function Score as well as the reduction in rates of infection, reoperation, and anterior knee pain. RESULTS: A total of 394 studies were initially included in this MA. About 20 randomized controlled trials which met the inclusion criteria were finally enrolled in this MA. The results of our MA showed that the reoperation rate of the patellar resurfacing group was lower than that of the nonresurfacing group. The subgroup analysis was performed according to the follow-up time and revealed that the increase in the Knee Society Clinical Score was higher in the patellar resurfacing group than that in the nonresurfacing group in the follow-up period of 1 to 2 years. The risk of reoperation rate was lower in the patellar resurfacing group than that in the nonresurfacing group, while there were no statistical differences in the follow-up time over 2 years. CONCLUSION: Our study suggests that during the follow-up of 1 to 2 years, patellar resurfacing can significantly increase the Knee Society Clinical Score and reduce the reoperative rates in patients with knee osteoarthritis.
BACKGROUND: This meta-analysis (MA) aims at comparing the clinical outcomes of resurfacing and nonresurfacing the patella in patients undergoing total knee arthroplasty in the treatment of knee osteoarthritis. METHODS: Randomized controlled trials were included by retrieving data from electronic English databases. Both fixed and random-effects models were employed, and standardized mean difference and 95% confidence intervals were calculated. Stata13.1 software was used for statistical analysis for all the studies included to compare the differences in improving Knee Society Clinical Score and Knee Society Function Score as well as the reduction in rates of infection, reoperation, and anterior knee pain. RESULTS: A total of 394 studies were initially included in this MA. About 20 randomized controlled trials which met the inclusion criteria were finally enrolled in this MA. The results of our MA showed that the reoperation rate of the patellar resurfacing group was lower than that of the nonresurfacing group. The subgroup analysis was performed according to the follow-up time and revealed that the increase in the Knee Society Clinical Score was higher in the patellar resurfacing group than that in the nonresurfacing group in the follow-up period of 1 to 2 years. The risk of reoperation rate was lower in the patellar resurfacing group than that in the nonresurfacing group, while there were no statistical differences in the follow-up time over 2 years. CONCLUSION: Our study suggests that during the follow-up of 1 to 2 years, patellar resurfacing can significantly increase the Knee Society Clinical Score and reduce the reoperative rates in patients with knee osteoarthritis.
Authors: Alberto Delgado-González; Juan José Morales-Viaji; Jose Gregorio Arteaga-Hernández; Ángela Larrosa-Arranz; Guillerno Criado-Albillos; Adoración Del Pilar Martin-Rodríguez; Maha Jahouh; Josefa González-Santos; Leticia Mendieta Díaz; Carla Collazo Riobo; Sara Calvo Simal; Jerónimo Javier González-Bernal Journal: Medicina (Kaunas) Date: 2022-02-02 Impact factor: 2.430
Authors: Erin M Macri; Marienke van Middelkoop; Jurgen Damen; P Koen Bos; Sita Ma Bierma-Zeinstra Journal: BMC Musculoskelet Disord Date: 2022-06-22 Impact factor: 2.562